HaidongDongMD

PubMed

• Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1.
  Yan Luo, Martha E Gadd, Yaqing Qie, Andrea Otamendi-Lopez, Jesus E Sanchez-Garavito
  Molecular Therapy. Oncology. 2024-12-19
• Synthesis and evaluation of anti-PD-L1-B11 antibody fragments for PET imaging of PD-L1 in breast cancer and melanoma tumor models.
  Aditya Bansal, Roxane R Lavoie, Fabrice Lucien, Manasa Kethamreddy, Bharath Wootla
  Scientific Reports. 2024-08-22
• TBK1 and IKKε protect target cells from IFNγ-mediated T cell killing via an inflammatory apoptotic mechanism.
  Nicholas D Sun, Allison R Carr, Erica N Krogman, Yogesh Chawla, Jun Zhong
  Biorxiv. 2024-08-08

Journal Articles

• Exosomal PD-L1 Contributes to Immunosuppression and Is Associated with Anti-PD-1 Response  
  Xiaowei Xu, Haidong Dong, Tara C Mitchell, Lynn M Schuchter, Alexander C Huang, Suzanne McGettigan, Wei Xu, Giorgos C Karakousis, Xiaoming Liu, Gordon Mills, Nature

Abstracts/Posters

• Tumor ADAM10/ADAM17-Mediated PD-L1 Loss May Predict Poor Outcomes in Diffuse Large B Cell Lymphoma
  Haidong Dong, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019